Peripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationBlood PlateletsAntineoplastic Combined Chemotherapy ProtocolsTransplantation, AutologousHematopoietic Stem Cell MobilizationPlatelet AggregationHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorPlatelet CountLeukapheresisStem Cell TransplantationCord Blood Stem Cell TransplantationTransplantation, HomologousCombined Modality TherapyBlood Component RemovalAntigens, CD34CyclophosphamideEmbryonic Stem CellsChemotherapy, AdjuvantTransplantation ConditioningPlatelet AdhesivenessAdult Stem CellsMelphalanTreatment OutcomeHematologic NeoplasmsGraft vs Host DiseaseBone Marrow TransplantationPluripotent Stem CellsPlatelet TransfusionPlatelet Membrane GlycoproteinsEtoposideGraft SurvivalStem Cell NicheMultiple MyelomaCell DifferentiationBlood Cell CountAntineoplastic AgentsDoxorubicinAntineoplastic Agents, AlkylatingNeural Stem CellsBlood CellsBusulfanHematopoiesisDisease-Free SurvivalInduced Pluripotent Stem CellsLymphoma, Non-HodgkinStem Cell FactorPlatelet Factor 4CisplatinThiotepaSurvival RateFetal BloodSurvival AnalysisMultipotent Stem CellsMesenchymal Stem Cell TransplantationRecurrenceIfosfamideTime FactorsMesenchymal Stromal CellsCell LineageCytarabineBreast NeoplasmsSalvage TherapyTissue DonorsNeoplasmsBone Marrow CellsMyeloablative AgonistsThrombocytopeniaFlow CytometryWhole-Body IrradiationPlatelet Activating FactorLeukemiaPlatelet Glycoprotein GPIIb-IIIa ComplexCarboplatinHodgkin DiseasePlatelet Function TestsCells, CulturedRemission InductionColony-Forming Units AssayTransplantation ChimeraCell SeparationPrognosisMethotrexateHistocompatibilityPlatelet Glycoprotein GPIb-IX ComplexBone MarrowRecombinant ProteinsInfectionLeukemia, Myeloid, AcuteDrug Administration ScheduleFollow-Up StudiesLymphomaVidarabineHematologic DiseasesStem Cell ResearchHistocompatibility TestingBlood DonorsThrombin